PARA vs TMDX · rev $5.0M vs P/E 17, rev $363.9M
PARA (PARA) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
PARA (PARA) common stock.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
PARA currently screens at market cap $0. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the PARA and TMDX stock pages for the full models.
Not investment advice.